Application 208564
- Type
- NDA
- Sponsor
- THERAPEUTICSMD INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IMVEXXY | ESTRADIOL | INSERT;VAGINAL | 0.004MG | Yes | No |
| 002 | IMVEXXY | ESTRADIOL | INSERT;VAGINAL | 0.01MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N208564-001 | IMVEXXY | ESTRADIOL | 0.004MG | INSERT / VAGINAL | AB | RLD, RS | 2018-05-29 |
| N208564-002 | IMVEXXY | ESTRADIOL | 0.01MG | INSERT / VAGINAL | AB | RLD, RS | 2018-05-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N208564-001 | AB |
| N208564-002 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N208564-001 | 10258630 | 2032-11-21 | U-2316 | 2019-04-18 | |
| N208564-001 | 10258630 | 2032-11-21 | U-2317 | 2019-04-18 | |
| N208564-001 | 10398708 | 2032-11-21 | U-2317 | 2019-09-12 | |
| N208564-001 | 10398708 | 2032-11-21 | U-2614 | 2019-09-12 | |
| N208564-001 | 10471072 | 2032-11-21 | U-2316 | 2019-12-06 | |
| N208564-001 | 10471072 | 2032-11-21 | U-2317 | 2019-12-06 | |
| N208564-001 | 10537581 | 2032-11-21 | U-2316 | Drug product | 2020-02-13 |
| N208564-001 | 10537581 | 2032-11-21 | U-2317 | Drug product | 2020-02-13 |
| N208564-001 | 10568891 | 2032-11-21 | U-2316 | 2020-03-19 | |
| N208564-001 | 10568891 | 2032-11-21 | U-2317 | 2020-03-19 | |
| N208564-001 | 10668082 | 2032-11-21 | U-2316 | 2020-06-10 | |
| N208564-001 | 10668082 | 2032-11-21 | U-2317 | 2020-06-10 | |
| N208564-001 | 10806697 | 2032-11-21 | Drug product | 2020-10-22 | |
| N208564-001 | 10835487 | 2032-11-21 | U-2316 | 2020-11-18 | |
| N208564-001 | 10835487 | 2032-11-21 | U-2317 | 2020-11-18 | |
| N208564-001 | 10888516 | 2032-11-21 | U-2316 | 2021-02-08 | |
| N208564-001 | 10888516 | 2032-11-21 | U-2317 | 2021-02-08 | |
| N208564-001 | 11065197 | 2032-11-21 | Drug product | 2021-08-05 | |
| N208564-001 | 11116717 | 2032-11-21 | Drug product | 2021-09-24 | |
| N208564-001 | 11123283 | 2032-11-21 | Drug product | 2021-09-24 | |
| N208564-001 | 11241445 | 2032-11-21 | U-2316 | 2022-02-18 | |
| N208564-001 | 11241445 | 2032-11-21 | U-2317 | 2022-02-18 | |
| N208564-001 | 11246875 | 2032-11-21 | U-2316 | 2022-02-18 | |
| N208564-001 | 11246875 | 2032-11-21 | U-2317 | 2022-02-18 | |
| N208564-001 | 11304959 | 2032-11-21 | Drug product | 2022-04-20 | |
| N208564-001 | 11351182 | 2032-11-21 | U-2316 | 2022-06-09 | |
| N208564-001 | 11351182 | 2032-11-21 | U-2317 | 2022-06-09 | |
| N208564-001 | 9180091 | 2032-11-21 | U-2316 | Drug product | 2018-06-19 |
| N208564-001 | 9180091 | 2032-11-21 | U-2317 | Drug product | 2018-06-19 |
| N208564-001 | 9289382 | 2032-11-21 | Drug product | 2018-06-19 | |
| N208564-001 | 11266661 | 2034-02-02 | U-2316 | 2022-03-11 | |
| N208564-001 | 11266661 | 2034-02-02 | U-2317 | 2022-03-11 | |
| N208564-002 | 10258630 | 2032-11-21 | U-2316 | 2019-04-18 | |
| N208564-002 | 10258630 | 2032-11-21 | U-2317 | 2019-04-18 | |
| N208564-002 | 10398708 | 2032-11-21 | U-2317 | 2019-09-12 | |
| N208564-002 | 10398708 | 2032-11-21 | U-2614 | 2019-09-12 | |
| N208564-002 | 10471072 | 2032-11-21 | U-2316 | 2019-12-06 | |
| N208564-002 | 10471072 | 2032-11-21 | U-2317 | 2019-12-06 | |
| N208564-002 | 10537581 | 2032-11-21 | U-2316 | Drug product | 2020-02-13 |
| N208564-002 | 10537581 | 2032-11-21 | U-2317 | Drug product | 2020-02-13 |
| N208564-002 | 10568891 | 2032-11-21 | U-2316 | 2020-03-19 | |
| N208564-002 | 10568891 | 2032-11-21 | U-2317 | 2020-03-19 | |
| N208564-002 | 10668082 | 2032-11-21 | U-2316 | 2020-06-10 | |
| N208564-002 | 10668082 | 2032-11-21 | U-2317 | 2020-06-10 | |
| N208564-002 | 10806697 | 2032-11-21 | Drug product | 2020-10-22 | |
| N208564-002 | 10835487 | 2032-11-21 | U-2316 | 2020-11-18 | |
| N208564-002 | 10835487 | 2032-11-21 | U-2317 | 2020-11-18 | |
| N208564-002 | 10888516 | 2032-11-21 | U-2316 | 2021-02-08 | |
| N208564-002 | 10888516 | 2032-11-21 | U-2317 | 2021-02-08 | |
| N208564-002 | 11065197 | 2032-11-21 | Drug product | 2021-08-05 | |
| N208564-002 | 11116717 | 2032-11-21 | Drug product | 2021-09-24 | |
| N208564-002 | 11123283 | 2032-11-21 | Drug product | 2021-09-24 | |
| N208564-002 | 11241445 | 2032-11-21 | U-2316 | 2022-02-18 | |
| N208564-002 | 11241445 | 2032-11-21 | U-2317 | 2022-02-18 | |
| N208564-002 | 11246875 | 2032-11-21 | U-2316 | 2022-02-18 | |
| N208564-002 | 11246875 | 2032-11-21 | U-2317 | 2022-02-18 | |
| N208564-002 | 11304959 | 2032-11-21 | Drug product | 2022-04-20 | |
| N208564-002 | 11351182 | 2032-11-21 | U-2316 | 2022-06-09 | |
| N208564-002 | 11351182 | 2032-11-21 | U-2317 | 2022-06-09 | |
| N208564-002 | 11497709 | 2032-11-21 | U-2316 | 2022-11-21 | |
| N208564-002 | 11497709 | 2032-11-21 | U-2317 | 2022-11-21 | |
| N208564-002 | 9180091 | 2032-11-21 | U-2316 | Drug product | 2018-06-19 |
| N208564-002 | 9180091 | 2032-11-21 | U-2317 | Drug product | 2018-06-19 |
| N208564-002 | 9289382 | 2032-11-21 | Drug product | 2018-06-19 | |
| N208564-002 | 11266661 | 2034-02-02 | U-2316 | 2022-03-11 | |
| N208564-002 | 11266661 | 2034-02-02 | U-2317 | 2022-03-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | AB | RLD, RS | 2018-05-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | AB | RLD, RS | 2018-05-29 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | AB | RLD | 2018-05-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | AB | RLD, RS | 2018-05-29 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N208564-001 | IMVEXXY | 0.004MG | INSERT / VAGINAL | RLD | 2018-05-29 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N208564-002 | IMVEXXY | 0.01MG | INSERT / VAGINAL | RLD, RS | 2018-05-29 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208564-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208564-002 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N208564-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N208564-002 | AB | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10258630 | 2032-11-21 | U-2316 | 2019-04-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10258630 | 2032-11-21 | U-2317 | 2019-04-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10398708 | 2032-11-21 | U-2317 | 2019-09-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10398708 | 2032-11-21 | U-2614 | 2019-09-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10471072 | 2032-11-21 | U-2317 | 2019-12-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10471072 | 2032-11-21 | U-2316 | 2019-12-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10537581 | 2032-11-21 | U-2316 | Drug product | 2020-02-13 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10537581 | 2032-11-21 | U-2317 | Drug product | 2020-02-13 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10568891 | 2032-11-21 | U-2316 | 2020-03-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10568891 | 2032-11-21 | U-2317 | 2020-03-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10668082 | 2032-11-21 | U-2317 | 2020-06-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10668082 | 2032-11-21 | U-2316 | 2020-06-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10806697 | 2032-11-21 | Drug product | 2020-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10835487 | 2032-11-21 | U-2316 | 2020-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10835487 | 2032-11-21 | U-2317 | 2020-11-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10888516 | 2032-11-21 | U-2316 | 2021-02-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 10888516 | 2032-11-21 | U-2317 | 2021-02-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11065197 | 2032-11-21 | Drug product | 2021-08-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11116717 | 2032-11-21 | Drug product | 2021-09-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11123283 | 2032-11-21 | Drug product | 2021-09-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11241445 | 2032-11-21 | U-2316 | 2022-02-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11241445 | 2032-11-21 | U-2317 | 2022-02-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11246875 | 2032-11-21 | U-2316 | 2022-02-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11246875 | 2032-11-21 | U-2317 | 2022-02-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11304959 | 2032-11-21 | Drug product | 2022-04-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11351182 | 2032-11-21 | U-2316 | 2022-06-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11351182 | 2032-11-21 | U-2317 | 2022-06-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 9180091 | 2032-11-21 | U-2317 | Drug product | 2018-06-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 9180091 | 2032-11-21 | U-2316 | Drug product | 2018-06-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 9289382 | 2032-11-21 | Drug product | 2018-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11266661 | 2034-02-02 | U-2316 | 2022-03-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-001 | 11266661 | 2034-02-02 | U-2317 | 2022-03-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10258630 | 2032-11-21 | U-2316 | 2019-04-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10258630 | 2032-11-21 | U-2317 | 2019-04-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10398708 | 2032-11-21 | U-2317 | 2019-09-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10398708 | 2032-11-21 | U-2614 | 2019-09-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10471072 | 2032-11-21 | U-2317 | 2019-12-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10471072 | 2032-11-21 | U-2316 | 2019-12-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10537581 | 2032-11-21 | U-2317 | Drug product | 2020-02-13 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208564-002 | 10537581 | 2032-11-21 | U-2316 | Drug product | 2020-02-13 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N208564-001 | NP | 2021-05-29 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N208564-002 | NP | 2021-05-29 | 74a2ff9319b5… |
| 2021-12-28 21:50 UTC | 2021-12 | N208564-001 | NP | 2021-05-29 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N208564-002 | NP | 2021-05-29 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N208564-001 | NP | 2021-05-29 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N208564-002 | NP | 2021-05-29 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N208564-001 | NP | 2021-05-29 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N208564-002 | NP | 2021-05-29 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N208564-001 | NP | 2021-05-29 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N208564-002 | NP | 2021-05-29 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N208564-001 | NP | 2021-05-29 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N208564-002 | NP | 2021-05-29 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N208564-001 | NP | 2021-05-29 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N208564-002 | NP | 2021-05-29 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N208564-001 | NP | 2021-05-29 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N208564-002 | NP | 2021-05-29 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N208564-001 | NP | 2021-05-29 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N208564-002 | NP | 2021-05-29 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| estradiol | ESTRADIOL | Zydus Pharmaceuticals USA Inc. | db4696da-7820-4b2b-97b4-fb05b1208020 | 2024-03-20 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Zydus Pharmaceuticals USA Inc. | 839fe7ae-6835-4d6a-b6b1-ca7f062caa4f | 2024-03-15 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Sandoz Inc | c4da6de7-9ab1-4fcf-88f3-fe785019e6e7 | 2024-02-29 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Minivelle | ESTRADIOL | Noven Therapeutics, LLC | 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | 2024-02-22 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Teva Pharmaceuticals USA, Inc. | c4936878-1643-4e7f-9b0d-e4957935aef2 | 2024-02-01 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ELESTRIN | ESTRADIOL | Viatris Specialty LLC | eff2dea1-f117-11e3-ac10-0800200c9a66 | 2023-12-15 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 31646359-292c-4bca-88a4-7a89b11c3f44 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Vivelle-Dot | ESTRADIOL | Sandoz Inc | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estrogen 4X | ESTRADIOL | Nutritional Specialties, Inc. | 772c2a8a-10e2-49af-8db6-4d5ca64b1719 | 2023-07-25 | Warnings | ESTRADIOL |
| estradiol | ESTRADIOL | Zydus Lifesciences Limited | 2f2030c2-f72e-4142-9cff-540bc8fbf8a1 | 2023-04-21 | ESTRADIOL | |
| estradiol | ESTRADIOL | Zydus Lifesciences Limited | 8b672c79-0896-4d6e-b225-299e89068ad7 | 2023-04-21 | ESTRADIOL | |
| Estradiol | ESTRADIOL | Zydus Lifesciences Limited | b79fd5ea-962f-491c-b670-40efe42ccf79 | 2022-12-07 | ESTRADIOL | |
| ESTRADIOL | ESTRADIOL | Asclemed USA, Inc. | 229b4ec5-d3c8-4406-9fc5-8f633c6447b8 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | PharmPak, Inc. | 8f8c5a0b-4d7b-a5cb-e053-2995a90a494e | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50261-104 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-104 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-104 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-104 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-104 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-104 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-104 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-110 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-110 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-110 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-110 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-110 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-110 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |
| 50261-110 | IMVEXXY | estradiol | TherapeuticsMD, Inc. | NDA | Current |